The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Open accessAbstract
BACKGROUND: Biomarkers for predicting cardiovascular events in community-based populations have not consistently added information to standard risk factors. A limitation of many previously studied biomarkers is their lack of cardiovascular specificity. METHODS AND RESULTS: To determine the prognostic value of 3 novel biomarkers induced by cardiovascular stress, we measured soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I in 3428 participants (mean age, 59 years; 53% women) in the Framingham Heart Study. We performed multivariable-adjusted proportional hazards models to assess the individual and combined ability of the biomarkers to predict adverse outcomes. We also constructed a "multimarker" score composed of the 3 biomarkers in addition to B-type natriuretic peptide and high-sensitivity C-reactive protein. During a mean follow-up of 11.3 years, there were 488 deaths, 336 major cardiovascular events, 162 heart failure events, and 142 coronary events. In multivariable-adjusted models, the 3 new biomarkers were associated with each end point (P<0.001) except coronary events. Individuals with multimarker scores in the highest quartile had a 3-fold risk of death (adjusted hazard ratio, 3.2; 95% confidence interval, 2.2-4.7; P<0.001), 6-fold risk of heart failure (6.2; 95% confidence interval, 2.6-14.8; P<0.001), and 2-fold risk of cardiovascular events (1.9; 95% confidence interval, 1.3-2.7; P=0.001). Addition of the multimarker score to clinical variables led to significant increases in the c statistic (P=0.005 or lower) and net reclassification improvement (P=0.001 or lower). CONCLUSION: Multiple biomarkers of cardiovascular stress are detectable in ambulatory individuals and add prognostic value to standard risk factors for predicting death, overall cardiovascular events, and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated serum GDF15 level have also been found in patients with heart failure”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Steyerberg, E. W. (2010) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,483
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,976
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D. A., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,521
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 482
Schopfer, D. W., Ku, I. A., Regan, M. C., & Whooley, M. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.09.013 · Cited by 64
High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure
Yan, I., Börschel, C. S., Neumann, F., Sprünker, N.-A., Makarova, N., Kontto, J. P., Kuulasmaa, K., Salomaa, V. V., Magnussen, C., Iacoviello, L., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.008 · Cited by 63
Sánchez‐Más, J., Lax, A., Asensio‐López, M. D. C., Palacio, M. J. F., Caballero, L., Santarelli, G., Januzzi, J. L., & Pascual-Figal, D. A. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12282 · Cited by 62
Clerico, A., Zaninotto, M., Passino, C., Aspromonte, N., Piepoli, M. F., Migliardi, M., Perrone, M. A., Fortunato, A., Padoan, A., Testa, A., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0310 · Cited by 61
Eggers, K. M., Alshakarchi, J. S. H., Berglund, L., Lindahl, B., Siegbahn, A. G., Wallentin, L. C., & Zethelius, B. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.07.004 · Cited by 61
Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study
Nayor, M. G., Enserro, D. M., Vasan, R. S., & Xanthakis, V. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002416 · Cited by 62
Plasma proteomics to identify biomarkers – application to cardiovascular diseases
Beck, H. C., Overgaard, M., & Rasmussen, L. M. (2015) · Translational Proteomics · doi:10.1016/j.trprot.2015.01.001 · Cited by 62
Santema, B. T., Chan, M. M. Y., Tromp, J., Dokter, M. M., van der Wal, H. H., Emmens, J. E., Takens, J., Samani, N. J., Ng, L. L., Lang, C. C., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01513-y · Cited by 58
Risk-Based Approach for the Prediction and Prevention of Heart Failure
Sinha, A., Gupta, D. K., Yancy, C. W., Shah, S. J., Rasmussen‐Torvik, L. J., McNally, E. M., Greenland, P., Lloyd‐Jones, D. M., & Khan, S. S. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007761 · Cited by 57
McKie, P. M., AbouEzzeddine, O. F., Scott, C. G., Mehta, R. A., Rodeheffer, R. J., Redfield, M. M., Burnett, J. C. J., & Jaffe, A. S. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.222778 · Cited by 57
Eltoft, A., Arntzen, K. A., Wilsgaard, T., Mathiesen, E. B., & Johnsen, S. H. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.005 · Cited by 57
Kuster, N., Huet, F., Dupuy, A., Akodad, M., Battistella, P., Agullo, A., Leclercq, F., Kalmanovich, E., Meilhac, A., Aguilhon, S., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12680 · Cited by 57
Scott, J. M., Armenian, S. H., Giralt, S. A., Moslehi, J. J., Wang, T. J., & Jones, L. W. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.11.007 · Cited by 59
Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community
Januzzi, J. L., Lyass, A., Liu, Y., Gaggin, H. K., Trebnick, A., Maisel, A. S., D’Agostino, R. B., Wang, T. J., Massaro, J. M., & Vasan, R. S. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307847 · Cited by 55
Wu, A. H. B., & Christenson, R. H. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.013 · Cited by 57
Clinical use of novel biomarkers in heart failure: towards personalized medicine
Schmitter, D., Cotter, G., & Voors, A. A. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9396-5 · Cited by 55
Tonkin, A. M., Blankenberg, S., Kirby, A. C., Zeller, T., Colquhoun, D. M., Funke-Kaiser, A., Hague, W. E., Hunt, D. U., KEECH, A. C., Nestel, P. J., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.07.080 · Cited by 55
Welsh, P. I., Woodward, M., Hillis, G. S., Li, Q., Marre, M., Williams, B., Poulter, N. R., RYAN, L. M., Harrap, S. B., Patel, A. A., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2625 · Cited by 53
Jacobs, L., Efremov, L., Ferreira, J. P., Thijs, L., Yang, W., Zhang, Z., Latini, R., Masson, S., Agabiti, N., Sever, P. S., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005231 · Cited by 53
Ohkuma, T., Jun, M., Woodward, M., Zoungas, S., Cooper, M. E., Grobbee, D. E., Hamet, P., Mancia, G., Williams, B., Welsh, P. I., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0509 · Cited by 57
ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality
Hughes, M., Appelbaum, S., Havulinna, A. S., Jagodzinski, A., Zeller, T., Kee, F., Blankenberg, S., & Salomaa, V. V. (2014) · Heart · doi:10.1136/heartjnl-2014-305968 · Cited by 52
Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: the CRIC study
Bansal, N., Zelnick, L. R., Shlipak, M., Anderson, A. H., Christenson, R., Deo, R., Defilippi, C., Feldman, H., Lash, J., He, J., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.305797 · Cited by 50
The Story of Growth Differentiation Factor 15: Another Piece of the Puzzle
Lindahl, B. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.212811 · Cited by 52
Jiang, J., Wen, W. X., & Sachdev, P. S. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000225 · Cited by 54
Scherzer, R., Shah, S. J., Secemsky, E. A., Butler, J., Grünfeld, C., Shlipak, M. G., & Hsue, P. Y. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004312 · Cited by 50
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Xiao, Q.-A., He, Q., Zeng, J., & Xia, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112582 · Cited by 50
Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
Riccardi, M., Myhre, P. L., Zelniker, T. A., Metra, M., Januzzi, J. L., & Inciardi, R. M. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10110468 · Cited by 49
An Automated Assay for Growth Differentiation Factor 15
Wollert, K. C., Kempf, T., Giannitsis, E., Bertsch, T., Braun, S., Maier, H., Reim, M., & Christenson, R. H. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.022376 · Cited by 49
Utility of Biomarkers to Improve Prediction of Readmission or Mortality After Cardiac Surgery
Brown, J. R., Jacobs, J. P., Alam, S. S., Thiessen‐Philbrook, H., Everett, A. D., Likosky, D. S., Lobdell, K. W., von Ballmoos, M. C. W., Parker, D. M., Garg, A. X., et al. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.06.052 · Cited by 48
Soluble ST2 predicts elevated SBP in the community
Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S. C., Vasan, R. S., Wang, T. J., & Januzzi, J. L. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283611bdf · Cited by 49
Metabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 48
The role of interleukins in heart failure with reduced ejection fraction
Segiet, O. A. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.32748 · Cited by 47
Niiranen, T., & Vasan, R. S. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1176528 · Cited by 49
García‐Osuna, Á., Gaze, D. C., Grau-Agramunt, M., Morris, T., Telha, C., Bartolome, A., Bishop, J. J., Monsalve, L., Livingston, R., Estis, J., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.08.015 · Cited by 46
Organocatalysis with carbon nitrides
Ruban, S. M., Ramadass, K., Singh, G., Talapaneni, S. N., Kamalakar, G., Gadipelly, C., Mannepalli, L. K., Sugi, Y., & Vinu, A. (2023) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2023.2188879 · Cited by 45
He, S., Ling, L., Wu, Y., Yang, S., Hua, Z., Tang, K., Wang, M., Zhu, M., & Fang, J. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c01989 · Cited by 44
Doerstling, S. S., Hedberg, P., Öhrvik, J., Leppert, J., & Henriksen, E. (2018) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2018.1460427 · Cited by 44
Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort
You, A. S., Kalantar-Zadeh, K., Lerner, L., Nakata, T., Lopez, N., Lou, L., Veliz, M., Soohoo, M., Jing, J., Zaldivar, F., et al. (2017) · Cardiorenal Medicine · doi:10.1159/000455907 · Cited by 43
Aimo, A., Georgiopoulos, G. A., Panichella, G., Vergaro, G., Passino, C., Emdin, M., & Clerico, A. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.01.012 · Cited by 44
Hsu, L., Wu, S., Juang, J. J., Chiang, F., Teng, M., Lin, J.-F., Huang, H., & Ko, Y. (2017) · Mediators of Inflammation · doi:10.1155/2017/9398401 · Cited by 43
Stelzle, D., Shah, A. S. V., Anand, A., Strachan, F. E., Chapman, A. R., Denvir, M. A., Mills, N. L., & McAllister, D. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcx022 · Cited by 44
Esteghamati, A., Hafezi‐Nejad, N., Zandieh, A., Sheikhbahaei, S., Ebadi, M., & Nakhjavani, M. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.02.001 · Cited by 43
Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently?
Motiwala, S. R., Sarma, A. A., Januzzi, J. L., & O’Donoghue, M. L. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.202531 · Cited by 43
Xie, S., Lu, L., & Liu, L. (2019) · Clinical Cardiology · doi:10.1002/clc.23159 · Cited by 42
Soluble ST2 and Galectin-3 in Heart Failure
Shah, R. V., & Januzzi, J. L. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.11.009 · Cited by 41
The mechanism by which moderate alcohol consumption influences coronary heart disease
Mathews, M. J., Liebenberg, L., & Mathews, E. H. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0011-6 · Cited by 43
D-dimer and the incidence of heart failure and mortality after acute myocardial infarction
Zhang, X., Wang, S., Liu, J., Wang, Y., Cai, H., Wang, D., Fang, S., & Yu, B. (2020) · Heart · doi:10.1136/heartjnl-2020-316880 · Cited by 42
Aeschbacher, S., Schoen, T., Bossard, M., van der Lely, S., Glättli, K., Todd, J., Estis, J., Risch, M., Mueller, C. E., Risch, L., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu226 · Cited by 41
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial
Januzzi, J. L., Mohebi, R., Liu, Y., Sattar, N. A., Heerspink, H. J. L., Tefera, E. A., Vaduganathan, M., Butler, J., Yavin, Y., Li, J., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065251 · Cited by 40
Yiu, K., Lau, K. K., Zhao, C., Chan, Y., Chen, Y., Zhen, Z., Wong, A., Lau, C., & Tse, H. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-63 · Cited by 40
Stanciu, A. E. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.002 · Cited by 42
Study, F. T. G. H., Sinning, C., Keller, T., Zeller, T., Ojeda, F., Schlüter, M., Schnabel, R. B., Lubos, E., Bickel, C., Lackner, K. J., et al. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0640-8 · Cited by 39
Dieplinger, B., Egger, M., Gegenhuber, A., Haltmayer, M., & Mueller, T. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.015 · Cited by 39
Towards a Multi-Marker Prognostic Strategy in Acute Heart Failure: A Role for GDF-15
Bettencourt, P., Ferreira‐Coimbra, J., Rodrigues, P., Marques, P. S., Moreira, H., Pinto, M. J., Guimarães, J. T., & Lourenço, P. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12301 · Cited by 39
Wang, Z., Yang, F., Ma, M., Bao, Q., Shen, J., Ye, F., & Xie, X. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01744-2 · Cited by 39
Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms
Dolivo, D., Reed, C. R., Gargiulo, K. A., Rodrigues, A. E., Galiano, R. D., Mustoe, T. A., & Hong, S. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115644 · Cited by 39
Zhu, K., Knuiman, M. W., Divitini, M., Murray, K., Lim, E. M., John, A. S., Walsh, J. P., & Hung, J. (2017) · Heart · doi:10.1136/heartjnl-2017-312093 · Cited by 38
Guerrero, C. D., Arrieta, A. F., Borrero, N. D. R., Rodríguez, L., Vega, R., Bosch, I., Rodríguez, J. A., Narváez, C. F., & Salgado, D. M. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.024 · Cited by 38
Patel, K. V., Segar, M. W., Klonoff, D. C., Khan, M. S., Usman, M. S., Lam, C. S. P., Verma, S., DeFilippis, A. P., Nasir, K., Bakker, S. J. L., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067530 · Cited by 38
The Use of Biomarkers in the Patient with Heart Failure
Chowdhury, P., Kehl, D. W., Choudhary, R., & Maisel, A. S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0372-4 · Cited by 37
Omland, T., Røsjø, H. R., Giannitsis, E., & Agewall, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.016 · Cited by 37
Biomarkers of Cardiovascular Stress and Subclinical Atherosclerosis in the Community
Gopal, D. M., Larson, M. G., Januzzi, J. L., Cheng, S. C., Ghorbani, A., Wollert, K. C., Kempf, T., D’Agostino, R. B., Polak, J. F., Vasan, R. S., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.227116 · Cited by 36
Herrington, W. G., Staplin, N., Judge, P. K., Mafham, M. M., Emberson, J., Haynes, R., Wheeler, D. C., Walker, R. J., Tomson, C., Agodoa, L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08386 · Cited by 37
Hamilton, M., Robb, Y., Cumming, S. A., Gregory, H., Duncan, A., Rahman, M., McKeown, A., McWilliam, C. A., Dean, J., Wilcox, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174166 · Cited by 37
Motiwala, S. R., Gaggin, H. K., Gandhi, P. U., Belcher, A. M., Weiner, R. B., Baggish, A. L., Szymonifka, J. D., & Januzzi, J. L. (2015) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-015-9618-4 · Cited by 37
Girerd, N., Levy, D. A., Duarte, K., Ferreira, J. P., Ballantyne, C. M., Collier, T. J., Pizard, A., Björkman, J., Butler, J., Clark, A. L., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.009694 · Cited by 40
deFilippi, C. R., Daniels, L. B., & Bayés‐Genís, A. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.042 · Cited by 36
Biomarker-Based Risk Prediction in the Community
AbouEzzeddine, O. F., McKie, P. M., Scott, C. G., Rodeheffer, R. J., Chen, H. H., Felker, G. M., Jaffe, A. S., Burnett, J. C. J., & Redfield, M. M. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.663 · Cited by 36
Dahou, A., Clavel, M.-A., Capoulade, R., O’Connor, K., Ribeiro, H. B., Côté, N., Le Ven, F., Rodés-Cabau, J., Dumesnil, J. G., Mathieu, P., et al. (2018) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.06.018 · Cited by 37
Bansal, N., Zelnick, L. R., Soliman, E. Z., Anderson, A. H., Christenson, R. H., deFilippi, C. R., Deo, R., Feldman, H. I., He, J., Ky, B., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.09.021 · Cited by 36
Gyanwali, B., Lai, M. K. P., Lui, B., Liew, O. W., Venketasubramanian, N., Richards, M., Chen, C., & Hilal, S. (2021) · Stroke · doi:10.1161/strokeaha.120.032571 · Cited by 35
Gopal, D. M., & Sam, F. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9462-3 · Cited by 35
Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination
Chida, A., Sato, H., Shintani, M., Nakayama, T., Kawamura, Y., Furutani, Y., Inai, K., Saji, T., Matsuoka, R., Nonoyama, S., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1033 · Cited by 35
Current Use of Cardiac Biomarkers in Various Heart Conditions
Khan, S. M., & Rasool, S. T. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320999200831171748 · Cited by 35
Imbalzano, E., Mandraffino, G., Casciaro, M., Quartuccio, S., Saitta, A., & Gangemi, S. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9529-8 · Cited by 35
Wolfson, J. A., Vock, D. M., Bandyopadhyay, S., Kottke, T. E., Vazquez‐Benitez, G., Johnson, P., Adomavičius, G., & O’Connor, P. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.003670 · Cited by 35
Prognostic value of soluble ST2 in adults with congenital heart disease
Geenen, L. W., Baggen, V. J. M., van den Bosch, A. E., Eindhoven, J. A., Cuypers, J. A. A. E., Witsenburg, M., Boersma, E. H., & Roos‐Hesselink, J. W. (2019) · Heart · doi:10.1136/heartjnl-2018-314168 · Cited by 34
Caselli, C., D’Amico, A., Ragusa, R., Caruso, R., Prescimone, T., Cabiati, M., Nonini, S., Marraccini, P., Ry, S. D., Trivella, M. G., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/498703 · Cited by 34
Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure
Chen, C., Qu, X., Gao, Z., Zheng, G., Wang, Y., Chen, X., Li, H., Huang, W., & Zhou, H. (2017) · International Heart Journal · doi:10.1536/ihj.16-520 · Cited by 34
Torrungruang, K., Katudat, D., Mahanonda, R., Sritara, P., & Udomsak, A. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13149 · Cited by 34
Biomarkers of Coronary Artery Disease: The Promise of the Transcriptome
Siemelink, M. A., & Zeller, T. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0513-4 · Cited by 34
Kimenai, D. M., Martens, R. J. H., Kooman, J. P., Stehouwer, C. D. A., Tan, F. E. S., Schaper, N. C., Dagnelie, P. C., Schram, M. T., Kallen, C., Sep, S. J. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06978-3 · Cited by 33
Cardiac Troponins As Biomarkers for Cardiac Disease
Passino, C., Aimo, A., Masotti, S., Musetti, V., Prontera, C., Emdin, M., & Clerico, A. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0039 · Cited by 33
Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes
Kim, A. J., Ro, H., Kim, H., Chang, J. H., Lee, H. H., Chung, W., & Jung, J. Y. (2021) · American Journal of Nephrology · doi:10.1159/000513663 · Cited by 33
Shiina, K., Tomiyama, H., Tanaka, A., Yoshida, H., Eguchi, K., Kario, K., Kato, T., Teragawa, H., Toyoda, S., Ohishi, M., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00857-9 · Cited by 33
Bakhshi, H., Michelhaugh, S. A., Bruce, S. A., Seliger, S. L., Qian, X., Ambale‐Venkatesh, B., Varadarajan, V., Bagchi, P., Lima, J. A. C., & deFilippi, C. R. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104490 · Cited by 35
GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes
Pávó, N., Wurm, R., Neuhold, S., Adlbrecht, C., Vila, G., Strunk, G., Clodi, M., Resl, M., Brath, H., Prager, R., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257212 · Cited by 33
Jain, M. K., Attur, M. G., Furer, V., Todd, J. A., Ramírez, R. F., Lock, M. D., Lu, Q. A., Abramson, S. B., & Greenberg, J. D. (2014) · Inflammation · doi:10.1007/s10753-014-0020-1 · Cited by 32
Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population
Shemisa, K., Bhatt, A. B., Cheeran, D. D., & Neeland, I. J. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0342-z · Cited by 32
GDF-15 is associated with sudden cardiac death due to incident myocardial infarction
Andersson, J. S. O., Fall, T., Delicano, R. A., Wennberg, P., & Jansson, J. (2020) · Resuscitation · doi:10.1016/j.resuscitation.2020.05.001 · Cited by 32
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Chianca, M., Panichella, G., Fabiani, I., Giannoni, A., L’Abbate, S., Aimo, A., Franco, A. D., Vergaro, G., Grigoratos, C., Castiglione, V., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.936654 · Cited by 33
Petersen, T. B., de Bakker, M., Asselbergs, F. W., Harakaľová, M., Akkerhuis, K. M., Brugts, J. J., van Ramshorst, J., Lumbers, R. T., Ostroff, R. M., Katsikis, P. D., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104655 · Cited by 32
Karayannis, G., Triposkiadis, F. K., Skoularigis, J. S., Georgoulias, P., Butler, J., & Giamouzis, G. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0169-1 · Cited by 31
Biofunctionalized Rebar Graphene (f-RG) for Label-Free Detection of Cardiac Marker Troponin I
Tuteja, S. K., Sabherwal, P., Deep, A., Rastogi, R. P., Paul, A. K., & Suri, C. R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am503524e · Cited by 31
B-Type Natriuretic Peptides Improve Cardiovascular Disease Risk Prediction in a Cohort of Women
Everett, B. M., Berger, J. S., Manson, J. E., Ridker, P. M., & Cook, N. R. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.089 · Cited by 31
Gaggin, H. K., Dang, P. V., Do, D. L., deFilippi, C. R., Christenson, R. H., Lewandrowski, E. L., Lewandrowski, K. B., Truong, B. Q., Pham, V. Q., Vũ, V. H., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.216275 · Cited by 31
Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide
Schiffmann, R., Forni, S., Swift, C., Brignol, N., Wu, X., Lockhart, D. J., Blankenship, D., Wang, X., Grayburn, P. A., Taylor, M. R. G., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000394 · Cited by 30
Fluschnik, N., Ojeda, F., Zeller, T., Jørgensen, T., Kuulasmaa, K., Becher, P. M., Sinning, C., Blankenberg, S., & Westermann, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197497 · Cited by 30
Novel insights on the role of spexin as a biomarker of obesity and related cardiometabolic disease
Kumar, S., Mankowski, R. T., Anton, S. D., & Balagopal, P. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00906-2 · Cited by 30
Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study
Echouffo-Tcheugui, J. B., Daya, N. R., Ndumele, C. E., Matsushita, K., Hoogeveen, R. C., Ballantyne, C. M., Coresh, J., Shah, A. M., & Selvin, E. (2022) · Diabetologia · doi:10.1007/s00125-022-05678-6 · Cited by 32
Metadata
- Authors
- Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., Kempf, T., Benjamin, E. J., Levy, D., Vasan, R. S., & Januzzi, J. L.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Circulation
- Published
- 2012-09-25
- Volume
- 126
- Issue
- 13
- Pages
- 1596-1604
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC3656719
- OpenAlex
- W2163917890
- Cited by
- 482
- References
- 65
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 29 · 2023: 33 · 2022: 25 · 2021: 32 · 2020: 40 · 2019: 42 · 2018: 31 · 2017: 42 · 2016: 45 · 2015: 38 · 2014: 44 · 2013: 43 · 2012: 6
- FWCI
- 32.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (R01HL086875, N01‐HC25195, K99HL107642, R01-HL-08675, N01-HC-025195)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble ST2, growth differentiation factor 15, high-sensitivity troponin I, cardiovascular mortality, heart failure, major cardiovascular events, brain natriuretic peptide, C-reactive protein, prognostic value, Framingham Heart Study
- MeSH terms
- Interleukin-1 Receptor-Like 1 Protein, Aged, C-Reactive Protein, Cardiovascular Diseases, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Prognosis, Receptors, Cell Surface, Retrospective Studies, Risk Factors, Biomarkers, Proportional Hazards Models, Troponin I, Natriuretic Peptide, Brain, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
